Literature DB >> 1850917

Expression of human papillomavirus proteins in yeast Saccharomyces cerevisiae.

J J Carter1, N Yaegashi, S A Jenison, D A Galloway.   

Abstract

The L1 and L2 proteins of human papillomavirus (HPV) types 1, 6, and 16 and the E6 and E7 proteins of HPV 16 were expressed in Saccharomyces cerevisiae. The yeast expressed proteins were readily detected by immune blotting and were generally intact. The HPV 1 L1 and L2 proteins expressed in yeast were indistinguishable from the major and minor capsid proteins purified from HPV 1 virions as judged by gel electrophoresis and immunoblotting. The HPV 6 and HPV 16 L2 proteins and HPV 16 E7 proteins were secreted from yeast by fusion to the yeast pre-pro-alpha-factor leader sequence. Following secretion of the HPV 16 E7 protein a rapid method of purification was developed. The yeast expressed proteins were used as antigen targets to study the human immune response in Western blot assay, ELISA, and immune precipitation. One human serum reacted with intact, but not denatured HPV 16 L2 proteins, suggesting that the yeast expressed proteins will be useful to detect antibodies reactive with conformational epitopes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850917     DOI: 10.1016/0042-6822(91)90592-y

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Production of human papillomavirus type 16 E7 protein in Lactococcus lactis.

Authors:  L G Bermúdez-Humarán; P Langella; A Miyoshi; A Gruss; R Tamez Guerra; Roberto Montes de Oca-Luna; Yves Le Loir
Journal:  Appl Environ Microbiol       Date:  2002-02       Impact factor: 4.792

2.  Study of infectious virus production from HPV18/16 capsid chimeras.

Authors:  Horng-Shen Chen; Jennifer Bromberg-White; Michael J Conway; Samina Alam; Craig Meyers
Journal:  Virology       Date:  2010-07-03       Impact factor: 3.616

3.  Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies.

Authors:  Joshua W Wang; Subhashini Jagu; Kihyuck Kwak; Chenguang Wang; Shiwen Peng; Reinhard Kirnbauer; Richard B S Roden
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

4.  Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7.

Authors:  C G Ullman; P I Haris; D A Galloway; V C Emery; S J Perkins
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

5.  Interaction of the E1A oncoprotein with Yak1p, a novel regulator of yeast pseudohyphal differentiation, and related mammalian kinases.

Authors:  Z Zhang; M M Smith; J S Mymryk
Journal:  Mol Biol Cell       Date:  2001-03       Impact factor: 4.138

6.  Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16.

Authors:  G J Fernando; B Murray; J Zhou; I H Frazer
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

7.  Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.

Authors:  T C Wu; F G Guarnieri; K F Staveley-O'Carroll; R P Viscidi; H I Levitsky; L Hedrick; K R Cho; J T August; D M Pardoll
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

8.  Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris.

Authors:  Silvia Boschi Bazan; Agtha de Alencar Muniz Chaves; Karina Araújo Aires; Aurora Marques Cianciarullo; Robert L Garcea; Paulo Lee Ho
Journal:  Arch Virol       Date:  2009-09-10       Impact factor: 2.574

9.  Recombinant HPV16 E7 assembled into particles induces an immune response and specific tumour protection administered without adjuvant in an animal model.

Authors:  Linda Petrone; Maria G Ammendolia; Armando Cesolini; Stefano Caimi; Fabiana Superti; Colomba Giorgi; Paola Di Bonito
Journal:  J Transl Med       Date:  2011-05-18       Impact factor: 5.531

10.  Head-to-Head Comparison of Modular Vaccines Developed Using Different Capsid Virus-Like Particle Backbones and Antigen Conjugation Systems.

Authors:  Laurits Fredsgaard; Louise Goksøyr; Susan Thrane; Kara-Lee Aves; Thor G Theander; Adam F Sander
Journal:  Vaccines (Basel)       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.